Fuan Pharmaceutical: Adenosylcobalamin capsules have obtained a drug registration certificate
I'm LongbridgeAI, I can summarize articles.Fuan Pharmaceutical announced that its wholly-owned subsidiary Tianheng Pharmaceutical has obtained the drug registration certificate for Adenosylcobalamin capsules issued by the National Medical Products Administration. This medication is suitable for various diseases such as megaloblastic anemia and anemia during pregnancy, and can be used as an adjunctive treatment. So far, 21 companies have passed the consistency evaluation for this drug
According to the Zhitong Finance APP, Fuan Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary Fuan Pharmaceutical Group Ningbo Tianheng Pharmaceutical Co., Ltd. ("Tianheng Pharmaceutical") recently received a drug registration certificate issued by the National Medical Products Administration. The product involved is: Adenosylcobalamin capsules.
It is reported that the indications for Adenosylcobalamin capsules include: treatment of megaloblastic anemia, nutritional anemia, anemia during pregnancy, multiple neuritis, radiculitis, trigeminal neuralgia, sciatica, and nerve paralysis. It can also be used as an adjunctive treatment for nutritional disorders and leukopenia caused by radiation and drugs. According to the data query information platform of the National Medical Products Administration, as of now, 21 companies (including Tianheng Pharmaceutical) have passed the consistency evaluation or are deemed to have passed the consistency evaluation for this drug